$NVLX Headlines Marijuana is a booming boomer
Post# of 94339
Posted On: 10/16/2014 11:30:13 AM
$NVLX Headlines
Marijuana is a booming boomer business 5:00 a.m. July 15, 2014 - Robyn Griggs Lawrence
10-Q: NUVILEX, INC. 8:26 a.m. Sept. 15, 2014 - Edgar Online - (EDG = 10Q, 10K)
10-K: NUVILEX, INC. 8:15 a.m. Aug. 4, 2014 - Edgar Online - (EDG = 10Q, 10K)
The Two Marijuana Stocks Held By Gurus 2:55 p.m. July 14, 2014 - GuruFocus.com
News flash: DirectView acquires office space 9:30 a.m. May 29, 2014 - Seeking Alpha
Minnesota moves closer to approving medical pot use 9:01 a.m. May 7, 2014 - Seeking Alpha
Growlife: Why It Got Halted And What You Need To Know Before Trading Resumes On Friday, April 25th 9:03 a.m. April 25, 2014 - Seeking Alpha
A Cannabis Stock Risk Management Tool 2:31 p.m. April 17, 2014 - Seeking Alpha
New Definitions Define Companies In The Marijuana Business 5:13 p.m. April 3, 2014 - Seeking Alpha
Securities Fraud Accusations And Misrepresentations Leave Vapor Group Up In Smoke 9:38 p.m. March 27, 2014 - Seeking Alpha
Cannabis companies on the move 11:44 a.m. March 25, 2014 - Seeking Alpha
Nuvilex - Another Cannabis Story Stock 2:05 p.m. March 18, 2014 - Seeking Alpha
Cannabis Stocks' High Hopes Of Uplisting 10:03 a.m. March 3, 2014 - Seeking Alpha
Nuvilex: Paid Promotion Marijuana Bubble Set To Burst 12:07 p.m. Feb. 28, 2014 - Seeking Alpha
10-Q: NUVILEX, INC. 7:07 a.m. Dec. 16, 2013 - Edgar Online - (EDG = 10Q, 10K)
Newly Transformed Nuvilex To Enjoy Strong 2014 12:33 p.m. Dec. 10, 2013 - Seeking Alpha
An Ongoing Debate: Is Nuvilex For Real? 3:19 p.m. Nov. 5, 2013 - Seeking Alpha
10-Q: NUVILEX, INC. 6:03 a.m. Sept. 16, 2013 - Edgar Online - (EDG = 10Q, 10K)
10-K: NUVILEX, INC. 4:21 p.m. July 29, 2013 - Edgar Online - (EDG = 10Q, 10K)
Nuvilex Secures Worldwide License for Insulin-Producing Cells From University of Technology, Sydney, for Use in Developing Diabetes Treatment 9:00 a.m. Today - GlobeNewswire
Nuvilex's Cancer Treatment Obtaining FDA Orphan Drug Status Would Make Company Attractive Big Pharma Target 9:10 a.m. Oct. 14, 2014 - Marketwired
Nuvilex Applies to FDA for Orphan Drug Designation for Its Cell-in-a-Box(R) Treatment for Pancreatic Cancer 9:01 a.m. Oct. 13, 2014 - GlobeNewswire
Online Medical Marijuana & CBD Dispensary Directory Provides Patients with User-Friendly Cannabis App to Identify Products, Various Strains & Dispensary Locations 8:30 a.m. Oct. 7, 2014 - PR Newswire - PRF
Copper Mugs Gift Packs that are Attractive and Functional are Now Available from Paykoc Imports 6:07 a.m. Oct. 7, 2014 - ACCESSWIRE
Nuvilex Appoints Dr. Matthias Lohr as Chairman of Scientific Advisory Board 9:00 a.m. Oct. 6, 2014 - GlobeNewswire
Nuvilex Announces Strategic Changes to Leadership Team and Appoints Prof. Dr. Walter H. Gunzburg as Chief Scientific Officer 9:00 a.m. Oct. 1, 2014 - GlobeNewswire
Nuvilex's Partner, Austrianova, Publishes Scientific Review Article Emphasizing Use of Cell-in-a-Box(R) for Treatment of Diabetes 9:00 a.m. Sept. 22, 2014 - GlobeNewswire
Nuvilex Updates Shareholders on Recent Activities and Discusses Future Plans for Development of Treatments for Cancer and Diabetes 10:50 a.m. Sept. 18, 2014 - GlobeNewswire
Nuvilex Updates Shareholders on Recent Activities and Discusses Future Plans for Development of Treatments for Cancer and Diabetes 9:25 a.m. Sept. 18, 2014 - GlobeNewswire
Cannabis Support on the Rise as Nuvilex and mCig Move Higher 12:01 p.m. Sept. 8, 2014 - ACCESSWIRE
Nuvilex's Partner, Austrianova, Receives Prestigious Emerging Enterprises 2014 Best Innovation Award in Singapore 1:23 p.m. Sept. 5, 2014 - GlobeNewswire
Nuvilex Aims for Market Exclusivity with Orphan Drug Status While Eyeing Larger Cancer Market for Cell-in-a-Box Technology 9:06 a.m. Sept. 5, 2014 - ACCESSWIRE
Nuvilex Submits Application for Orphan Drug Designation to the European Medicines Agency for Its Cell-in-a-Box(R) Treatment for Pancreatic Cancer 9:01 a.m. Sept. 2, 2014 - GlobeNewswire
Nuvilex Begins Preclinical Studies With Translational Drug Development to Determine if Nuvilex's Unique Cancer Treatment Can Slow Accumulation of Malignant Ascites Fluid 9:01 a.m. Aug. 20, 2014 - GlobeNewswire
Small Business Operations to Large Scale Companies Take Steps to Increase Security Surveillance - Company Selected for Comprehensive Cannabis Security System Installation 9:05 a.m. Aug. 14, 2014 - PR Newswire - PRF
Nuvilex Announces Publication of Combined Results of the Initial Phase 1/2 Clinical Trial and a Second Phase 2 Clinical Trial of the Cell-in-a-Box(R) Plus Ifosfamide Combination in Patients With Advanced, Inoperable Pancreatic Cancer 9:00 a.m. Aug. 14, 2014 - GlobeNewswire
Nuvilex Provides Update on Status of Preclinical Studies at Translational Drug Development 9:00 a.m. Aug. 13, 2014 - GlobeNewswire
Nuvilex Announces That Dr. Richard M. Hyslop Will Present at the ACS Annual Meeting on "Sustainable, Green Chemistry and Medicine: Targeted Cannabinoid-Based Chemotherapy Utilizing Cell-in-a-Box(R) Live Cell Encapsulation Technology." 9:46 a.m. Aug. 4, 2014 - GlobeNewswire
OTC Trading Stock News: Digipath, Inc. Immune Pharmaceuticals, Inc. Vuzix Corp, Nuvilex, Inc. Origin Oil, Inc. 8:06 a.m. July 29, 2014 - PR Newswire - PRF
Marijuana is a booming boomer business 5:00 a.m. July 15, 2014 - Robyn Griggs Lawrence
10-Q: NUVILEX, INC. 8:26 a.m. Sept. 15, 2014 - Edgar Online - (EDG = 10Q, 10K)
10-K: NUVILEX, INC. 8:15 a.m. Aug. 4, 2014 - Edgar Online - (EDG = 10Q, 10K)
The Two Marijuana Stocks Held By Gurus 2:55 p.m. July 14, 2014 - GuruFocus.com
News flash: DirectView acquires office space 9:30 a.m. May 29, 2014 - Seeking Alpha
Minnesota moves closer to approving medical pot use 9:01 a.m. May 7, 2014 - Seeking Alpha
Growlife: Why It Got Halted And What You Need To Know Before Trading Resumes On Friday, April 25th 9:03 a.m. April 25, 2014 - Seeking Alpha
A Cannabis Stock Risk Management Tool 2:31 p.m. April 17, 2014 - Seeking Alpha
New Definitions Define Companies In The Marijuana Business 5:13 p.m. April 3, 2014 - Seeking Alpha
Securities Fraud Accusations And Misrepresentations Leave Vapor Group Up In Smoke 9:38 p.m. March 27, 2014 - Seeking Alpha
Cannabis companies on the move 11:44 a.m. March 25, 2014 - Seeking Alpha
Nuvilex - Another Cannabis Story Stock 2:05 p.m. March 18, 2014 - Seeking Alpha
Cannabis Stocks' High Hopes Of Uplisting 10:03 a.m. March 3, 2014 - Seeking Alpha
Nuvilex: Paid Promotion Marijuana Bubble Set To Burst 12:07 p.m. Feb. 28, 2014 - Seeking Alpha
10-Q: NUVILEX, INC. 7:07 a.m. Dec. 16, 2013 - Edgar Online - (EDG = 10Q, 10K)
Newly Transformed Nuvilex To Enjoy Strong 2014 12:33 p.m. Dec. 10, 2013 - Seeking Alpha
An Ongoing Debate: Is Nuvilex For Real? 3:19 p.m. Nov. 5, 2013 - Seeking Alpha
10-Q: NUVILEX, INC. 6:03 a.m. Sept. 16, 2013 - Edgar Online - (EDG = 10Q, 10K)
10-K: NUVILEX, INC. 4:21 p.m. July 29, 2013 - Edgar Online - (EDG = 10Q, 10K)
Nuvilex Secures Worldwide License for Insulin-Producing Cells From University of Technology, Sydney, for Use in Developing Diabetes Treatment 9:00 a.m. Today - GlobeNewswire
Nuvilex's Cancer Treatment Obtaining FDA Orphan Drug Status Would Make Company Attractive Big Pharma Target 9:10 a.m. Oct. 14, 2014 - Marketwired
Nuvilex Applies to FDA for Orphan Drug Designation for Its Cell-in-a-Box(R) Treatment for Pancreatic Cancer 9:01 a.m. Oct. 13, 2014 - GlobeNewswire
Online Medical Marijuana & CBD Dispensary Directory Provides Patients with User-Friendly Cannabis App to Identify Products, Various Strains & Dispensary Locations 8:30 a.m. Oct. 7, 2014 - PR Newswire - PRF
Copper Mugs Gift Packs that are Attractive and Functional are Now Available from Paykoc Imports 6:07 a.m. Oct. 7, 2014 - ACCESSWIRE
Nuvilex Appoints Dr. Matthias Lohr as Chairman of Scientific Advisory Board 9:00 a.m. Oct. 6, 2014 - GlobeNewswire
Nuvilex Announces Strategic Changes to Leadership Team and Appoints Prof. Dr. Walter H. Gunzburg as Chief Scientific Officer 9:00 a.m. Oct. 1, 2014 - GlobeNewswire
Nuvilex's Partner, Austrianova, Publishes Scientific Review Article Emphasizing Use of Cell-in-a-Box(R) for Treatment of Diabetes 9:00 a.m. Sept. 22, 2014 - GlobeNewswire
Nuvilex Updates Shareholders on Recent Activities and Discusses Future Plans for Development of Treatments for Cancer and Diabetes 10:50 a.m. Sept. 18, 2014 - GlobeNewswire
Nuvilex Updates Shareholders on Recent Activities and Discusses Future Plans for Development of Treatments for Cancer and Diabetes 9:25 a.m. Sept. 18, 2014 - GlobeNewswire
Cannabis Support on the Rise as Nuvilex and mCig Move Higher 12:01 p.m. Sept. 8, 2014 - ACCESSWIRE
Nuvilex's Partner, Austrianova, Receives Prestigious Emerging Enterprises 2014 Best Innovation Award in Singapore 1:23 p.m. Sept. 5, 2014 - GlobeNewswire
Nuvilex Aims for Market Exclusivity with Orphan Drug Status While Eyeing Larger Cancer Market for Cell-in-a-Box Technology 9:06 a.m. Sept. 5, 2014 - ACCESSWIRE
Nuvilex Submits Application for Orphan Drug Designation to the European Medicines Agency for Its Cell-in-a-Box(R) Treatment for Pancreatic Cancer 9:01 a.m. Sept. 2, 2014 - GlobeNewswire
Nuvilex Begins Preclinical Studies With Translational Drug Development to Determine if Nuvilex's Unique Cancer Treatment Can Slow Accumulation of Malignant Ascites Fluid 9:01 a.m. Aug. 20, 2014 - GlobeNewswire
Small Business Operations to Large Scale Companies Take Steps to Increase Security Surveillance - Company Selected for Comprehensive Cannabis Security System Installation 9:05 a.m. Aug. 14, 2014 - PR Newswire - PRF
Nuvilex Announces Publication of Combined Results of the Initial Phase 1/2 Clinical Trial and a Second Phase 2 Clinical Trial of the Cell-in-a-Box(R) Plus Ifosfamide Combination in Patients With Advanced, Inoperable Pancreatic Cancer 9:00 a.m. Aug. 14, 2014 - GlobeNewswire
Nuvilex Provides Update on Status of Preclinical Studies at Translational Drug Development 9:00 a.m. Aug. 13, 2014 - GlobeNewswire
Nuvilex Announces That Dr. Richard M. Hyslop Will Present at the ACS Annual Meeting on "Sustainable, Green Chemistry and Medicine: Targeted Cannabinoid-Based Chemotherapy Utilizing Cell-in-a-Box(R) Live Cell Encapsulation Technology." 9:46 a.m. Aug. 4, 2014 - GlobeNewswire
OTC Trading Stock News: Digipath, Inc. Immune Pharmaceuticals, Inc. Vuzix Corp, Nuvilex, Inc. Origin Oil, Inc. 8:06 a.m. July 29, 2014 - PR Newswire - PRF
(0)
(0)